| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Liquidia Corp | Director | Common Stock | 20.4K | $296K | $14.55 | Jun 20, 2024 | Direct |
| Vyant Bio, Inc. | Director | Common Stock, $0.0001 par value | 23.1K | $30.8K | $1.33 | Jan 17, 2023 | Direct |
| Kymera Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $33.11 | Jun 7, 2024 | Direct |
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 33.2K | Jun 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LQDA | Liquidia Corp | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 7, 2024 | 4 | -$263K | 4 | Jun 7, 2024 | Director |
| LQDA | Liquidia Corp | Jun 19, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
| VYNT | Vyant Bio, Inc. | Jan 17, 2023 | 1 | $0 | 4 | Jan 19, 2023 | Director |
| VYNT | Vyant Bio, Inc. | Oct 17, 2022 | 1 | $0 | 4 | Oct 19, 2022 | Director |
| VYNT | Vyant Bio, Inc. | Jul 18, 2022 | 1 | $0 | 4 | Jul 29, 2022 | Director |
| LQDA | Liquidia Corp | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
| VYNT | Vyant Bio, Inc. | Apr 18, 2022 | 1 | $0 | 4 | Apr 19, 2022 | Director |
| VYNT | Vyant Bio, Inc. | Mar 30, 2022 | 1 | $0 | 4 | Apr 1, 2022 | Director |
| VYNT | Vyant Bio, Inc. | Jan 18, 2022 | 1 | $7K | 4 | Jan 20, 2022 | Director |
| LQDA | Liquidia Corp | Aug 20, 2021 | 1 | $0 | 4 | Sep 1, 2021 | Director |
| KYMR | Kymera Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |